|Articles|January 1, 2012
- BioPharm International-01-01-2012
- Volume 25
- Issue 1
BioPharm International, January 2012 Issue (PDF)
Therapeutic Vaccines
Advertisement
Articles in this issue
about 14 years ago
Auditing by the Numbersabout 14 years ago
Here's to a Year of Compromiseabout 14 years ago
USAID Moves Global Healthcare Initiatives Forwardabout 14 years ago
Therapeutic Vaccine Outlookabout 14 years ago
Budget Crunch, Political Battles Shape Policy Agenda for Yearabout 14 years ago
A 25-Year Retrospective on Separations Technologyabout 14 years ago
Global Economic Woes Overshadow Biotech Industry Advances in 2011Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
5
